Beran, M., Hanak, P., Molik, P., Urban, M., Adamek, L., and Krajicek, M.: Aplikace fungálních chitosanů v biomateriálech.

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027022%3A_____%2F05%3A8P012106" target="_blank" >RIV/00027022:_____/05:8P012106 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Beran, M., Hanak, P., Molik, P., Urban, M., Adamek, L., and Krajicek, M.: Applications of fungal chitosans in biomaterials. The 8th Annual Meeting of Tissue Engineering Society International. October 22 -25, 2005. Shanghai. China.

Popis výsledku v původním jazyce

Chitosan and some of its complexes have been studied for use in biomedical applications such as wound dressing, drug delivery systems and space filling implants. Chitosan also has been reported to be a promising candidate as a scaffold material for engineered human tissue such as skin, cartilage and bone due to its biocompatibility and resorbability. Fungal mycelial wastes of the antibiotic, citric acid and other industry can become free and rich alternative sources of chitin - chitosan materials, beside the traditional industrial source - shellfish waste materials. Moreover, the fungal chitosans can have unique properties compared with those derived from Crustacea. Fungal chitosans has been extracted from Aspergillus niger and Penicillium oxalicum industrial biomass, purified and bleached. Several applications of the fungal chitosans in biomaterials have been tested: 1) composite fungal chitosan - collagen sponge material for wound healing or scaffolds for tissue engineering 2) nonwov

Název v anglickém jazyce

Beran, M., Hanak, P., Molik, P., Urban, M., Adamek, L., and Krajicek, M.: Applications of fungal chitosans in biomaterials. The 8th Annual Meeting of Tissue Engineering Society International. October 22 -25, 2005. Shanghai. China.

Popis výsledku anglicky

Chitosan and some of its complexes have been studied for use in biomedical applications such as wound dressing, drug delivery systems and space filling implants. Chitosan also has been reported to be a promising candidate as a scaffold material for engineered human tissue such as skin, cartilage and bone due to its biocompatibility and resorbability. Fungal mycelial wastes of the antibiotic, citric acid and other industry can become free and rich alternative sources of chitin - chitosan materials, beside the traditional industrial source - shellfish waste materials. Moreover, the fungal chitosans can have unique properties compared with those derived from Crustacea. Fungal chitosans has been extracted from Aspergillus niger and Penicillium oxalicum industrial biomass, purified and bleached. Several applications of the fungal chitosans in biomaterials have been tested: 1) composite fungal chitosan - collagen sponge material for wound healing or scaffolds for tissue engineering 2) nonwov

Druh

A - Audiovizuální tvorba

CEP obor

CE - Biochemie

OECD FORD obor

—

Projekt

<a href="/cs/project/QF3286" target="_blank" >QF3286: Perspektivní směry průmyslového využití odpadní plísňové biomasy z biotechnologických provozů.</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2005

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

ISBN

—

Místo vydání

—

Název nakladatele resp. objednatele

—

Verze

—

Identifikační číslo nosiče

—